Of note, IRAK4 signaling downstream of the IL-1 receptor or toll-like receptor family leads to increased NF-kB activity and promotes the dominance of MDS clones and a transition to AML [112]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.